Literature DB >> 28570538

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring.

Mitchell Dyer1, Shannon Haldeman2, Andres Gutierrez2, Lauryn Kohut2, Anirban Sen Gupta3, Matthew D Neal2.   

Abstract

Uncontrolled hemorrhage is an important cause of preventable deaths among trauma patients. We have developed a murine model of uncontrolled hemorrhage via a liver laceration that results in consistent blood loss, hemodynamic alterations, and survival. Mice undergo a standardized resection of the left-middle lobe of the liver. They are allowed to bleed without mechanical intervention. Hemostatic agents can be administered as pre-treatment or rescue therapy depending on the interest of the investigator. During the time of hemorrhage, real-time hemodynamic monitoring via a left femoral arterial line is performed. Mice are then sacrificed, blood loss is quantified, blood is collected for further analysis, and organs are harvested for analysis of injury. Experimental design is described to allow for simultaneous testing of multiple animals. Liver hemorrhage as a model of uncontrolled hemorrhage exists in the literature, primarily in rat and porcine models. Some of these models utilize hemodynamic monitoring or quantify blood loss but lack consistency. The present model incorporates quantification of blood loss, real-time hemodynamic monitoring in a murine model that offers the advantage of using transgenic lines and a high-throughput mechanism to further investigate the pathophysiologic mechanisms in uncontrolled hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28570538      PMCID: PMC5608008          DOI: 10.3791/55554

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

1.  Efficacy of a topical bovine-derived thrombin solution as a hemostatic agent in a rodent model of hepatic injury.

Authors:  Desiree D Rosselli; Benjamin M Brainard; Chad W Schmiedt
Journal:  Can J Vet Res       Date:  2015-10       Impact factor: 1.310

2.  Adhesive and robust multilayered poly(lactic acid) nanosheets for hemostatic dressing in liver injury model.

Authors:  Takuya Komachi; Hideaki Sumiyoshi; Yutaka Inagaki; Shinji Takeoka; Yu Nagase; Yosuke Okamura
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2016-05-14       Impact factor: 3.368

3.  Development of a Nonhuman Primate (Rhesus Macaque) Model of Uncontrolled Traumatic Liver Hemorrhage.

Authors:  Forest R Sheppard; Antoni Macko; Darren M Fryer; Kassandra M Ozuna; Alexander K Brown; Randy F Crossland; Douglas K Tadaki
Journal:  Shock       Date:  2015-08       Impact factor: 3.454

4.  Pseudofracture: an acute peripheral tissue trauma model.

Authors:  Sophie S Darwiche; Philipp Kobbe; Roman Pfeifer; Lauryn Kohut; Hans-Christoph Pape; Timothy Billiar
Journal:  J Vis Exp       Date:  2011-04-18       Impact factor: 1.355

5.  Liver injury as a model of uncontrolled hemorrhagic shock: resuscitation with different hypertonic regimens.

Authors:  T Matsuoka; J Hildreth; D H Wisner
Journal:  J Trauma       Date:  1995-10

6.  The effects of antioxidants on a porcine model of liver hemorrhage.

Authors:  Nikolaos F Orfanos; Anastasios I Mylonas; Iosifina I Karmaniolou; Irene P Stergiou; Evangelos D Lolis; Cleanthi Dimas; Apostolos E Papalois; Agathi I Kondi-Pafiti; Vasileios E Smyrniotis; Nikolaos F Arkadopoulos
Journal:  J Trauma Acute Care Surg       Date:  2016-06       Impact factor: 3.313

7.  In vitro and in vivo hemostatic capabilities of a functionally integrated platelet-mimetic liposomal nanoconstruct.

Authors:  Christa L Modery-Pawlowski; Lewis L Tian; Madhumitha Ravikumar; Timothy L Wong; Anirban Sen Gupta
Journal:  Biomaterials       Date:  2013-01-26       Impact factor: 12.479

Review 8.  Animal models for trauma research: what are the options?

Authors:  Takeshi Tsukamoto; Hans Christoph Pape
Journal:  Shock       Date:  2009-01       Impact factor: 3.454

Review 9.  Advances in the understanding of trauma-induced coagulopathy.

Authors:  Ronald Chang; Jessica C Cardenas; Charles E Wade; John B Holcomb
Journal:  Blood       Date:  2016-07-05       Impact factor: 22.113

10.  Fixed volume or fixed pressure: a murine model of hemorrhagic shock.

Authors:  Lauryn K Kohut; Sophie S Darwiche; John M Brumfield; Alicia M Frank; Timothy R Billiar
Journal:  J Vis Exp       Date:  2011-06-06       Impact factor: 1.355

View more
  4 in total

1.  Platelet-derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice.

Authors:  Mitchell R Dyer; Wyeth Alexander; Adnan Hassoune; Qiwei Chen; Tomasz Brzoska; Jurgis Alvikas; Yingjie Liu; Shannon Haldeman; Will Plautz; Patricia Loughran; Hui Li; Brian Boone; Yoel Sadovsky; Prithu Sundd; Brian S Zuckerbraun; Matthew D Neal
Journal:  J Thromb Haemost       Date:  2019-07-28       Impact factor: 5.824

2.  Intravenous administration of synthetic platelets (SynthoPlate) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis.

Authors:  Mitchell R Dyer; DaShawn Hickman; Norman Luc; Shannon Haldeman; Patricia Loughran; Christa Pawlowski; Anirban Sen Gupta; Matthew D Neal
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

3.  An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice.

Authors:  Bilgimol Chumappumkal Joseph; Byron Y Miyazawa; Charles T Esmon; Mitchell J Cohen; Annette von Drygalski; Laurent O Mosnier
Journal:  Blood Adv       Date:  2022-02-08

4.  Development of Optimized Tissue-Factor-Targeted Peptide Amphiphile Nanofibers to Slow Noncompressible Torso Hemorrhage.

Authors:  Mia K Klein; Hussein Aziz Kassam; Robert H Lee; Wolfgang Bergmeier; Erica B Peters; David C Gillis; Brooke R Dandurand; Jessica R Rouan; Mark R Karver; Mark D Struble; Tristan D Clemons; Liam C Palmer; Brian Gavitt; Timothy A Pritts; Nick D Tsihlis; Samuel I Stupp; Melina R Kibbe
Journal:  ACS Nano       Date:  2020-06-03       Impact factor: 15.881

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.